Status:
UNKNOWN
Turkish of the SARS-CoV-2 Anxiety Scale
Lead Sponsor:
DILEK SAYIK
Conditions:
Anxiety
SARS-CoV Infection
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The coronavirus outbreak has adversely affected individuals in the community, as in the rest of the world. However, in order to carry out this epidemic period in a healthy and conscious manner, determ...
Detailed Description
Coronaviruses can be seen in animals and humans as infections that can be mild and severe in society. The SARS-CoV-2 virus, a type of coronavirus, started in China in December 2019 and has spread worl...
Eligibility Criteria
Inclusion
- inclusion criteria;
- individuals agree to participate in the study
- 18 years old,
- Lack of visual obstacle,
- Knowing how to speak, read and write in Turkish.
- Exclusion criteria;
- individuals refuse to participate in the study
- 18 years old,
- Visually impaired,
- Does not know how to speak, read and write in Turkish
Exclusion
Key Trial Info
Start Date :
July 24 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 24 2021
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04490473
Start Date
July 24 2020
End Date
April 24 2021
Last Update
December 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eskisehir Osmangazi University
Eskişehir, Turkey (Türkiye)